Sponsor or institution
Clinical trials and research at Consegna Pharma, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Long-lasting naloxone to prevent repeat opioid overdoses
A new long-acting naloxone formulation designed to protect people who overdose on fentanyl and other powerful opioids from falling back into overdose.
-
Developing a long-lasting treatment for opioid overdose
This study is working on a new version of naloxone, a lifesaving medication for opioid overdoses, that could help keep people safe for up to 24 hours after an overdose, making it easier to manage these situations outside of hospitals.
-
Using long-lasting ketamine to treat substance use disorders without side effects.
This study is testing a new long-lasting injectable form of ketamine to help people with substance use disorders by reducing cravings and supporting recovery, while aiming to make the treatment easier to stick with and more comfortable.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.